drugset / Trial / NCT00631566

Prospective Study of Methicillin-Resistant Staphylococcus Aureus (MRSA) Among HIV-Infected Persons

NCT00631566 ↗

RandomizedParallel-groupDouble-blindTreatment

Summary

This study will prospectively evaluate the prevalence and incidence (over a two year period) of MRSA colonization and infection among HIV-infected military beneficiaries to determine predictors for the development of MRSA colonization and infection. This study will also investigate the utility of decolonization procedures for clearance of MRSA carriage and prevention of MRSA infections. Finally, the molecular characteristics and the antimicrobial sensitivities of isolates in this population will be determined.

Timeline

Start
2007-05
Primary completion
2017-05
Completion
2017-10

Outcome

Missed primary endpoint

paper Among those with 6-month colonization data (80% of those randomized), 67% were negative for MRSA colonization in both groups (p = 1.0). PMID 26018036 ↗

paper A one-week decolonization procedure had no effect on MRSA colonization at the 6-month time point or subsequent infection rates among community-dwelling HIV-infected persons. PMID 26018036 ↗

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Mupirocin Small molecule 2 % Intranasal
Subject hexachlorophene Small molecule 3 % Topical